Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $292.24 | 19 | 78.5% |
| Education | $79.99 | 1 | 21.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $79.99 | 1 | $0 (2018) |
| Mallinckrodt LLC | $75.62 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $44.46 | 2 | $0 (2018) |
| PFIZER INC. | $39.13 | 3 | $0 (2018) |
| Veloxis Pharmaceuticals, Inc. | $33.47 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $28.69 | 2 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $24.73 | 2 | $0 (2017) |
| GENZYME CORPORATION | $17.91 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $16.92 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $144.20 | 5 | SANOFI-AVENTIS U.S. LLC ($79.99) |
| 2017 | $228.03 | 15 | Mallinckrodt LLC ($62.68) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/15/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/18/2018 | SANOFI-AVENTIS U.S. LLC | ZALTRAP (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/05/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/28/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/03/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Immunology | ||||||
| 06/29/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/15/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 05/11/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/09/2017 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Immunology | ||||||
| 03/02/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunosuppressant | ||||||
| 02/23/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 02/02/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/26/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Immunology | ||||||
| 01/19/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,087 | 2,408 | $635,932 | $210,001 |
| 2022 | 9 | 642 | 1,277 | $305,630 | $95,977 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 114 | 326 | $82,611 | $29,702 | 36.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 129 | 443 | $78,390 | $28,152 | 35.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 112 | 224 | $56,722 | $20,281 | 35.8% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Office | 2023 | 39 | 98 | $56,972 | $19,868 | 34.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 122 | 289 | $51,101 | $18,409 | 36.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 59 | 150 | $51,051 | $15,161 | 29.7% |
| 11044 | Removal of bone, 20.0 sq cm or less | Office | 2023 | 23 | 42 | $32,097 | $11,804 | 36.8% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Facility | 2023 | 36 | 71 | $41,220 | $9,019 | 21.9% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 22 | 77 | $23,025 | $8,442 | 36.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 57 | 57 | $17,865 | $6,664 | 37.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 22 | 91 | $16,265 | $5,743 | 35.3% |
| 11044 | Removal of bone, 20.0 sq cm or less | Facility | 2023 | 15 | 27 | $20,614 | $5,283 | 25.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 18 | 34 | $12,329 | $4,501 | 36.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 50 | 96 | $32,636 | $4,405 | 13.5% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 14 | 49 | $11,558 | $3,689 | 31.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 63 | 100 | $9,470 | $3,393 | 35.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 27 | 27 | $8,462 | $3,197 | 37.8% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 38 | 38 | $7,177 | $2,645 | 36.9% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 16 | 27 | $6,588 | $2,490 | 37.8% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 20 | 20 | $6,705 | $2,465 | 36.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 61 | 70 | $6,621 | $2,418 | 36.5% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 18 | 40 | $4,194 | $1,496 | 35.7% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 12 | 12 | $2,260 | $772.59 | 34.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 79 | 233 | $38,389 | $14,244 | 37.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 72 | 152 | $32,689 | $12,178 | 37.3% |
About Dr. Seth Narins, MD
Dr. Seth Narins, MD is a Surgery healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356377832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Narins, MD has received a total of $372.23 in payments from pharmaceutical and medical device companies, with $144.20 received in 2018. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($292.24).
As a Medicare-enrolled provider, Narins has provided services to 1,729 Medicare beneficiaries, totaling 3,685 services with total Medicare billing of $305,978. Data is available for 2 years (2022–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Transplant Surgery
- Location Morristown, NJ
- Active Since 06/25/2006
- Last Updated 10/04/2023
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1356377832
Products in Payments
- ZALTRAP (Drug) $79.99
- ACTHAR (Biological) $75.62
- ZORTRESS (Drug) $44.46
- CHANTIX (Drug) $39.13
- Envarsus XR (Drug) $33.47
- NULOJIX (Biological) $28.69
- SOLIRIS (Drug) $24.73
- THYMOGLOBULIN (Drug) $17.91
- ZERBAXA (Drug) $16.92
- PRADAXA (Drug) $11.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Morristown
Eric Whitman, Md, MD
Surgery — Payments: $1.2M
Dr. Michael Hernando, M.d, M.D
Surgery — Payments: $17,462
Samuel Echeverri, Md, MD
Surgery — Payments: $9,982
Dr. Kai Bickenbach, Md, MD
Surgery — Payments: $9,535
Dr. Igor Elyash, D.o, D.O
Surgery — Payments: $6,274
Rachel Parker, Md, MD
Surgery — Payments: $4,545